News >

Testing Aims to Personalize Treatment, Predict Transplant Outcomes in Cholangiocarcinoma

Jessica Hergert
Published: Wednesday, Oct 02, 2019

Lewis R. Roberts, MB, ChB, PhD, a gastroenterologist, professor of medicine and director of the Hepatobiliary Neoplasia Clinic, Department of Gastroenterology and Hepatology, Mayo Clinic

Lewis R. Roberts, MB, ChB, PhD

A regimen of chemotherapy, radiation, and transplant has shown promise in the perihilar and intrahepatic subgroups of cholangiocarcinoma, said Lewis R. Roberts, MB, ChB, PhD, adding that personalized approaches are on the horizon to identify patients who will best respond to this approach.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication